Signaling to the p53 Tumor Suppressor through Pathways Activated by Genotoxic and Nongenotoxic Stresses

Handbook of Cell Signaling: Volume 1-3

Volumn 1-3, Issue , 2003, Pages 237-247

  Anderson, Carl W ^a   Appella, Ettore ^b  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84943232112     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012124546-7/50668-9     Document Type: Chapter

References (87)

1. M. Hollstein, D. Sidransky, B. Vogelstein and C.C. Harris (1991) p53 mutations in human cancers. Science 253 49-53.
2. É.E. Bálint and K.H. Vousden (2001) Activation and activities of the p53 tumour suppressor protein. Br. J. Cancer 85 1813-1823.
3. G.M. Wahl and A.M. Carr (2001) The evolution of diverse biological responses to DNA damage: Insights from yeast and p53. Nat. Cell Biol. 3 E277-E286.
4. R. Zhao, K. Gish, M. Murphy, Y. Yin, D. Notterman, W.H. Hoffman, E. Tom, D.H. Mack and A.J. Levine (2000) Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev. 14 981-993.
5. P.C. Hanawalt (2001) Controlling the efficiency of excision repair. Mutat. Res. 485 3-13.
6. M.L. Smith and Y.R. Seo (2002) p53 regulation of DNA excision repair pathways. Mutagenesis 17 149-156.
7. J. Campisi (2001) Cellular senescence as a tumor-suppressor mechanism. Trends Cell. Biol. 11 S27-S31.
8. P.H. Kussie, S. Gorina, V. Marechal, B. Elenbaas, J. Moreau, A.J. Levine and N.P. Pavletich (1996) Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274 948-953.
9. Y. Zhang and Y. Xiong (2001) A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation. Science 292 1910-1915.
10. J.T. Zilfou, W.H. Hoffman, M. Sank, D.L. George and M. Murphy (2001) The corepressor mSin3a interacts with the proline-rich domain of p53 and protects p53 from proteasome-mediated degradation. Mol. Cell. Biol. 21 3974-3985.
11. Y. Cho, S. Gorina, P.D. Jeffrey and N.P. Pavletich (1994) Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations. Science 265 346-355.
12. R. Wolkowicz and V. Rotter (1997) The DNA binding regulatory domain of p53: See the C. Pathol. Biol. (Paris) 45 785-796.
13. E. Appella and C.W. Anderson (2001) Post-translational modifications and activation of p53 by genotoxic stresses. Eur. J. Biochem. 268 2764-2772.
14. A. Gatti, H.-H. Li, J.A. Traugh and X. Liu (2000) Phosphorylation of human p53 on Thr-55. Biochemistry 39 9837-9842.
15. M.J.F. Waterman, E.S. Stavridi, J.L.F. Waterman and T.D. Halazonetis (1998) ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat. Genet. 19 175-178.
16. D. Bech-Otschir, R. Kraft, X. Huang, P. Henklein, B. Kapelari, C. Pollmann and W. Dubiel (2001) COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J. 20 1630-1639.
17. T. Buschmann, O. Potapova, A. Bar-Shira, V.N. Ivanov, S.Y. Fuchs, S. Henderson, V.A. Fried, T. Minamoto, D. Alarcon-Vargas, M.R. Pincus, W.A. Gaarde, N.J. Holbrook, Y. Shiloh and Z. Ronai (2001) Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress. Mol. Cell. Biol. 21 2743-2754.
18. J. Parant, A. Chavez-Reyes, N.A. Little, W. Yan, V. Reinke, A.G. Jochemsen and G. Lozano (2001) Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53. Nat. Genet. 29 92-95.
19. S.-Y. Shieh, M. Ikeda, Y. Taya and C. Prives (1997) DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91 325-334.
20. N.H. Chehab, A. Malikzay, E.S. Stavridi and T.D. Halazonetis (1999) Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. Proc. Natl. Acad. Sci. USA 96 13777-13782.
21. A.L. Craig, L. Burch, B. Vojtesek, J. Mikutowska, A. Thompson and T.R. Hupp (1999) Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers. Biochem. J. 342 133-141.
22. K. Sakaguchi, S. Saito, Y. Higashimoto, S. Roy, C.W. Anderson and E. Appella (2000) Damage-mediated phosphorylation of human p53 threonine 18 through a cascade mediated by a casein 1-like kinase. Effect on Mdm2 binding. J. Biol. Chem. 275 9278-9283.
23. T. Unger, T. Juven-Gershon, E. Moallem, M. Berger, R. Vogt Sionov, G. Lozano, M. Oren and Y. Haupt (1999) Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2. EMBO J. 18 1805-1814.
24. Z. Lai, K.R. Auger, C.M. Manubay and R.A. Copeland (2000) Thermodynamics of p53 binding to hdm2(1–126): Effects of phosphorylation and p53 peptide length. Arch. Biochem. Biophys. 381 278-284.
25. M. Fiscella, S.J. Ullrich, N. Zambrano, M.T. Shields, D. Lin, S.P. Lees-Miller, C.W. Anderson, W.E. Mercer and E. Appella (1993) The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities. Oncogene 8 1519-1528.
26. C. Chao, S. Saito, C.W. Anderson, E. Appella and Y. Xu (2000) Phosphorylation of murine p53 at Ser-18 regulates the p53 responses to DNA damage. Proc. Natl. Acad. Sci. USA 97 11936-11941.
27. P.F. Lambert, F. Kashanchi, M.F. Radonovich, R. Shiekhattar and J.N. Brady (1998) Phosphorylation of p53 serine 15 increases interaction with CBP. J. Biol. Chem. 273 33048-33053.
28. S. Saito, A.A. Goodarzi, Y. Higashimoto, Y. Noda, S.P. Lees-Miller, E. Appella and C.W. Anderson (2002) ATM mediates phosphorylation at multiple p53 sites, including Ser46, in response to ionizing radiation. J. Biol. Chem. 277 12491-12494.
29. Z. Wu, J. Earle, S. Saito, C.W. Anderson, E. Appella and Y. Xu (2002) Mutation of mouse p53 Ser23 and the response to DNA damage. Mol. Cell. Biol. 22 2441-2449.
30. C.J. Sherr (2001) The INK4a/ARF network in tumour suppression. Nat. Rev. Mol. Cell Biol. 2 731-737.
31. D. Michael and M. Oren (2002) The p53 and Mdm2 families in cancer. Curr. Opin. Genet. Dev. 12 53-59.
32. A.L. Talis, J.M. Huibregtse and P.M. Howley (1998) The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV) positive and HPV-negative cells. J. Biol. Chem. 273 6439-6445.
33. M.L. Agarwal, W.R. Taylor, M.V. Chernov, O.B. Chernova and G.R. Stark (1998) The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells. J. Biol. Chem. 273 1-4.
34. T.R. Hupp and D.P. Lane (1994) Allosteric activation of latent p53 tetramers. Curr. Biol. 4 865-875.
35. W. Gu and R.G. Roeder (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90 595-606.
36. K. Sakaguchi, J.E. Herrera, S. Saito, T. Miki, M. Bustin, A. Vassilev, C.W. Anderson and E. Appella (1998) DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 12 2831-2841.
37. M.E. Anderson, B. Woelker, M. Reed, P. Wang and P. Tegtmeyer (1997) Reciprocal interference between the sequence-specific core and nonspecific C-terminal DNA binding domains of p53: Implications for regulation. Mol. Cell. Biol. 17 6255-6264.
38. A. Ayed, F.A.A. Mulder, G.-S. Yi, Y. Lu, L.E. Kay and C.H. Arrowsmith (2001) Latent and active p53 are identical in conformation. Nat. Struct. Biol. 8 756-760.
39. J.M. Espinosa and B.M. Emerson (2001) Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Mol. Cell 8 57-69.
40. M.D. Kaeser and R.D. Iggo (2002) Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo. Proc. Natl. Acad. Sci. USA 99 95-100.
41. S. Nakamura, J.A. Roth and T. Mukhopadhyay (2000) Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination. Mol. Cell. Biol. 20 9391-9398.
42. L.-J. Juan, W.-J. Shia, M.-H. Chen, W.-M. Yang, E. Seto, Y.-S. Lin and C.-W. Wu (2000) Histone deacetylases specifically down-regulate p53-dependent gene activation. J. Biol. Chem. 275 20436-20443.
43. J. Luo, F. Su, D. Chen, A. Shiloh and W. Gu (2000) Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 408 377-381.
44. J. Luo, A.Y. Nikolaev, S. Imai, D. Chen, F. Su, A. Shiloh, L. Guarente and W. Gu (2001) Negative control of p53 by Sir2a promotes cell survival under stress. Cell 107 137-148.
45. H. Vaziri, S.K. Dessain, E.N. Eaton, S.I. Imai, R.A. Frye, T.K. Pandita, L. Guarente and R.A. Weinberg (2001) hSIR2SIRT1 functions as an NAD-dependent p53 deacetylase. Cell 107 149-159.
46. E. Langley, M. Pearson, M. Faretta, U.-M. Bauer, R.A. Frye, S. Minucci, P.G. Pelicci and T. Kouzarides (2002) Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J. 21 2383-2396.
47. M. Murphy, J. Ahn, K.K. Walker, W.H. Hoffman, R.M. Evans, A.J. Levine and D.L. George (1999) Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes Dev. 13 2490-2501.
48. N.A. Barlev, L. Liu, N.H. Chehab, K. Mansfield, K.G. Harris, T.D. Halazonetis and S.L. Berger (2001) Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol. Cell 8 1243-1254.
49. E. Kim, G. Rohaly, S. Heinrichs, D. Gimnopoulos, H. Meißner and W. Deppert (1999) Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53. Oncogene 18 7310-7318.
50. A.K. Nagaich, V.B. Zhurkin, S.R. Durell, R.L. Jernigan, E. Appella and R.E. Harrington (1999) p53-induced DNA bending and twisting: p53 tetramer binds on the outer side of a DNA loop and increases DNA twisting. Proc. Natl. Acad. Sci. USA 96 1875-1880.
51. C.D. Braastad, M. Leguia and E.A. Hendrickson (2002) Ku86 autoantigen related protein-1 transcription initiates from a CpG island and is induced by p53 through a nearby p53 response element. Nucleic Acids Res. 30 1713-1724.
52. E.A. Hendrickson (2003) Constitutive DNase I hypersensitivity of p53-regulated promoters. J. Biol. Chem. 278 8261-8268.
53. Y. Higashimoto, S. Saito, X.-H. Tong, A. Hong, K. Sakaguchi, E. Appella and C.W. Anderson (2000) Human p53 is phosphorylated on serines 6 and 9 in response to DNA damage-inducing agents. J. Biol. Chem. 275 23199-23203.
54. G. Achanta, H. Pelicano, L. Feng, W. Plunkett and P. Huang (2001) Interaction of p53 and DNA-PK in response to nucleoside analogues: Potential role as a sensor complex for DNA damage. Cancer Res. 61 8723-8729.
55. R.A. Woo, M.T. Jack, Y. Xu, S. Burma, D.J. Chen and P.W.K. Lee (2002) DNA damage-induced apoptosis requires the DNA-dependent protein kinase, and is mediated by the latent population of p53. EMBO J. 21 3000-3008.
56. G.S. Jimenez, F. Bryntesson, M.I. Torres-Arzayus, A. Priestley, M. Beeche, S. Saito, K. Sakaguchi, E. Appella, P.A. Jeggo, G.E. Taccioli, G.M. Wahl and M. Hubank (1999) DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage. Nature 400 81-83.
57. M. Ljungman, F. Zhang, F. Chen, A.J. Rainbow and B.C. McKay (1999) Inhibition of RNA polymerase II as a trigger for the p53 response. Oncogene 18 583-592.
58. R.T. Abraham (2001) Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 15 2177-2196.
59. K. ünsal-Kaçmaz, A.M. Malkhov, J.D. Griffith and A. Sancar (2002) Preferential binding of ATR protein to UV-damaged DNA. Proc. Natl. Acad. Sci. USA 99 6673-6678.
60. D.V. Bulavin, S. Saito, M.C. Hollander, K. Sakaguchi, C.W. Anderson, E. Appella and A.J. Fornace Jr. (1999) Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J. 18 6845-6854.
61. G. D'Orazi, B. Cecchinelli, T. Bruno, I. Manni, Y. Higashimoto, S. Saito, M. Gostissa, S. Coen, A. Marchetti, G. Del Sal, G. Piaggio, M. Fanciulli, E. Appella and S. Soddu (2002) Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat. Cell Biol. 4 11-19.
62. T.G. Hofmann, A. Möller, H. Sirma, H. Zentgraf, Y. Taya, W. Dröge, H. Will and M.L. Schmitz (2002) Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat. Cell Biol. 4 1-10.
63. D.M. Keller, X. Zeng, Y. Wang, Q.H. Zhang, M. Kapoor, H. Shu, R. Goodman, G. Lozano, Y. Zhao and H. Lu (2001) A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1. Mol. Cell 7 283-292.
64. K. Oda, H. Arakawa, T. Tanaka, K. Matsuda, C. Tanikawa, T. Mori, H. Nishimori, K. Tamai, T. Tokino, Y. Nakamura and Y. Taya (2000) p53AIP1 a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 102 849-862.
65. J.P. Blaydes, M.G. Luciani, S. Pospisilova, H.M.-L. Ball, B. Vojtesek and T.R. Hupp (2001) Stoichiometric phosphorylation of human p53 at Ser315 stimulates p53-dependent transcription. J. Biol. Chem. 14 4699-4708.
66. Y. Zhang, W.-Y. Ma, A. Kaji, A.M. Bode and Z. Dong (2002) Requirement of ATM in UVA-induced signaling and apoptosis. J. Biol. Chem. 277 3124-3131.
67. M.V. Chernov, L.J.H. Bean, N. Lerner and G.R. Stark (2001) Regulation of ubiquitination and degradation of p53 in unstressed cells through C-terminal phosphorylation. J. Biol. Chem. 276 31819-31824.
68. M. Fiscella, N. Zambrano, S. Ullrich, T. Unger, D. Lin, B. Cho, W. Mercer, C. Anderson and E. Appella (1994) Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression. Oncogene 9 3249-3257.
69. K. Sakaguchi, H. Sakamoto, D. Xie, J.W. Erickson, M.S. Lewis, C.W. Anderson and E. Appella (1997) Effect of phosphorylation on tetremerization of the tumor suppressor protein p53. J. Protein Chem. 16 553-556.
70. A. Ito, C.-H. Lai, X. Zhao, S. Saito, M.H. Hamilton, E. Appella and T.-P. Yao (2001) p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO J. 20 1331-1340.
71. M. Ljungman, H.M. O'Hagan and M.T. Paulsen (2001) Induction of ser 15 and lys382 modifications of p53 by blockage of transcription elongation. Oncogene 20 5964-5971.
72. R. Alarcón, C. Koumenis, R.K. Geyer, C.G. Maki and A.J. Giaccia (1999) Hypoxia induced p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation. Cancer Res. 59 6046-6051.
73. C. Koumenis, R. Alarcon, E. Hammond, P. Sutphin, W. Hoffman, M. Murphy, J. Derr, Y. Taya, S.W. Lowe, M. Kastan and A. Giaccia (2001) Regulation of p53 by hypoxia: Dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol. Cell. Biol. 21 1297-1310.
74. E.M. Hammond, N.C. Denko, M.J. Dorie, R.T. Abraham and A.J. Giaccia (2002) Hypoxia links ATR and p53 through replication arrest. Mol. Cell. Biol. 22 1834-1843.
75. S.P. Linke, K.C. Clarkin, A. Di Leonardo, A. Tsou and G.M. Wahl (1996) A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev. 10 934-947.
76. G. Seidita, D. Polizzi, G. Costanzo, S. Costa and A. Di Leonardo (2000) Differential gene expression in p53-mediated G1 arrest of human fibroblasts after γ-irradiation of N-phosphoacetyl-l-aspartate treatment. Carcinogenesis 21 2203-2210.
77. S.H. Khan and G.M. Wahl (1998) p53 and pRb prevent rereplication in response to microtubule inhibitors by mediating a reversible G1 arrest. Cancer Res. 58 396-401.
78. A.A. Sablina, P.M. Chumakov, A.J. Levine and B.P. Kopnin (2001) p53 activation in response to microtubule disruption is mediated by integrin-Erk signaling. Oncogene 20 899-909.
79. Z.A. Stewart, L.J. Tang and J.A. Pietenpol (2001) Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner. Oncogene 20 113-124.
80. G. Damia, L. Filiberti, F. Vikhanskaya, L. Carrassa, Y. Taya, M. D'incalci and M. Broggini (2001) Cisplatinum and taxol induce different patterns of p53 phosphorylation. Neoplasia 3 10-16.
81. E. de Stanchina, M.E. McCurrach, F. Zindy, G. Ferbeyre, A.V. Samuelson, C. Prives, M.F. Roussel, C.J. Sherr and S.W. Lowe (1998) E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev. 12 2434-2442.
82. O. Vafa, M. Wade, S. Kern, M. Beeche, T.K. Pandita, G.M. Hampton and G.M. Wahl (2002) c-myc Can induce DNA damage, increase reactive oxygen species, and mitigate p53 function. A mechanism for oncogene-induced genetic instability. Mol. Cell 9 1031-1044.
83. G. Ferbeyre, E. de Stanchina, E. Querido, N. Baptiste, C. Prives and S.W. Lowe (2000) PML is induced by oncogenic ras and promotes premature senescence. Genes Dev. 14 2015-2027.
84. D.V. Bulavin, O.N. Demidov, S. Saito, P. Kauraniemi, C. Phillips, S.A. Amundson, C. Ambrosino, G. Sauter, A.R. Nebreda, C.W. Anderson, A. Kallioniemi, A.J. Fornace Jr. and E. Appella (2002) Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat. Genet. 31 210-215.
85. G. Ferbeyre, E. de Stanchina, A.W. Lin, E. Querido, M.E. McCurrach, G.J. Hannon and S.W. Lowe (2002) Oncogenic ras and p53 cooperate to induce cellular senescence. Mol. Cell. Biol. 22 3497-3508.
86. K. Webley, J.A. Bond, C.J. Jones, J.P. Blaydes, A. Craig, T. Hupp and D. Wynford-Thomas (2000) Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage. Mol. Cell. Biol. 20 2803-2808.
87. J.M. Stommel, N.D. Marchenko, G.S. Jimenez, U.M. Moll, T.J. Hope and G.M. Wahl (1999) A leucine-rich nuclear export signal in the p53 tetramerization domain: Regulation of subcellular localization and p53 activity by NES masking. EMBO J. 18 1660-1672.